AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (Nasdaq:ARTC), a leader in developing state-of-the-art, minimally invasive surgical products today announced that its Board of Directors has approved the repurchase of up to $75 million of its outstanding common stock. The timing and amount of shares repurchased will be determined by the company’s management based on its evaluation of market conditions and other factors with a majority of the repurchases expected to be completed by March 31, 2008.
